NPI registry status
Active
2026 NPPES data Student in an Organized Health Care Education/Training Program NPI 1174765192 M.D.
Verify on CMS → Jingya Wang, M.D.
Student in an Organized Health Care Education/Training Program in Baton Rouge, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 351,014 in Student in an Organized Health Care Education/Training Program, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
416
Medicare Part D claims · 156 beneficiaries · Student in an Organized Health Care Education/Training Program avg: 488
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Jingya Wang, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 416 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 416
- Part D claims, 2024
- 95%
- generic prescribing
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jingya Wang, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174765192), first enumerated 04/06/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 416 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1174765192 · Student in an Organized Health Care Education/Training Program
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-NEUTRAL · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1174765192
- ENUM-MID 2009
- TAX-MEGA 351K Student in
- MIPS-NEUTRAL 75/100
- RX-LIGHT 416
- BOOK-LIGHT 4,673 in Louisiana
- PHOTO-ENUM Ramiro De Los Santos · 2009
Jingya Wang, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
416 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Jingya Wang, M.D.?
CMS neutral score, not measuredPrimary specialty
Student in an Organized Health Care Education/Training Program
Medicare Part D claims
416 15% vs specialty avg
MIPS final score
75/100
Specialty distribution in Louisiana
How Student in an Organized Health Care Education/Training Program compares to other specialties among Louisiana providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174765192 |
|---|---|
| Specialty | Student in an Organized Health Care Education/Training Program |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/06/2009 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Jingya Wang, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mary Bird Perkins Cancer Center
Hammond, LA
St. Elizabeth-Mary Bird Perkins Cancer Center, L.L.C.
Gonzales, LA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Generic-heavy
Jingya Wang, M.D. - brand share 5.0%
Student in an Organized Health Care Education/Training Program average
5% brand-name claims vs 95% generic, on 416 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
416
Total Claims
$6K
Total Drug Cost
156
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 454.533
- Total Day Supply
- 7,400
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $126
- Generic Drug Cost
- $6K
- Opioid Claims
- 64 (15.4% rate)
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 71.2 years
- Avg HCC Risk Score
- 2.21
- Gender Split
- 40% female / 60% male
- Age Distribution
- <65: 17, 65-74: 90, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jingya Wang, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Lidocaine Hcl Visc…
Lidocaine Hcl Viscous
59 claims
- Oxycodone Hcl
Oxycodone Hcl
37 claims
- Tamsulosin Hcl
Tamsulosin Hcl
36 claims
- Lorazepam
Lorazepam
30 claims
- Nystatin 22
Nystatin
22 claims
- Pentoxifylline 17
Pentoxifylline
17 claims
- Glycopyrrolate 16
Glycopyrrolate
16 claims
- Hydrocodone-Acetam… 14
Hydrocodone-Acetaminophen
14 claims
| Drug | Claims |
|---|---|
| Lidocaine Hcl Viscous Lidocaine Hcl | 59 |
| Oxycodone Hcl | 37 |
| Tamsulosin Hcl | 36 |
| Lorazepam | 30 |
| Nystatin | 22 |
| Pentoxifylline | 17 |
| Glycopyrrolate | 16 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 14 |
| Mometasone Furoate | 13 |
| Dexamethasone | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Student in an Organized Health Care Education/Training Program in LA →
All providers in Louisiana →
Compare specialties →
Student in an Organized Health Care Education/Training Program Overview
How Jingya Wang, M.D. fits within the Student in an Organized Health Care Education/Training Program landscape nationally.
351,014
Student in an Organized Health Care Education/Training Program Providers in US
55
States with Student in an Organized Health Care Education/Training Program
488
Avg Claims per Provider
Jingya Wang, M.D.'s 416 claims are below the specialty average of 488.
Nationwide Student in an Organized Health Care Education/Training Program peers with similar MIPS or enrollment year
Two federal-record peer sets for Wang, both outside Louisiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Student in an Organized Health Care Education/Training Program Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Wang.
One of 4,673 Student in an Organized Health Care Education/Training Program providers enrolled in Louisiana, 5 are shown here.
Frequently Asked Questions
What is Jingya Wang, M.D.'s specialty? ▼
Jingya Wang, M.D. specializes in Student in an Organized Health Care Education/Training Program and practices in Baton Rouge, Louisiana. Credentials: M.D..
How much does Jingya Wang, M.D. prescribe under Medicare Part D? ▼
In 2024, Jingya Wang, M.D. wrote 416 Medicare Part D claims totaling $6K in drug costs for 156 beneficiaries.
What is Jingya Wang, M.D.'s Medicare quality score? ▼
Jingya Wang, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jingya Wang, M.D. located? ▼
Jingya Wang, M.D. is located at 4950 ESSEN LN, Baton Rouge, LA, 70809. Phone: (225) 767-0847.
What is Jingya Wang, M.D.'s NPI number? ▼
Jingya Wang, M.D.'s National Provider Identifier (NPI) is 1174765192, issued on 04/06/2009.
Does Jingya Wang, M.D. prescribe more brand-name or generic drugs? ▼
Jingya Wang, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $126 in brand drug costs.
Does Jingya Wang, M.D. prescribe opioids? ▼
Yes, Jingya Wang, M.D. had 64 opioid claims in 2024 with an opioid prescribing rate of 15.4%.
How many Student in an Organized Health Care Education/Training Program providers are there in the US? ▼
There are 351,014 Student in an Organized Health Care Education/Training Program providers across 55 states in the US. The average Student in an Organized Health Care Education/Training Program provider writes 488 Medicare Part D claims per year.
What drugs does Jingya Wang, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Jingya Wang, M.D.'s most frequently prescribed drugs include Lidocaine Hcl Viscous, Oxycodone Hcl, Tamsulosin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jingya Wang, M.D. accept Medicare? ▼
Jingya Wang, M.D. appears in CMS Medicare data with 416 Part D claims and 156 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jingya Wang, M.D.'s credentials? ▼
Jingya Wang, M.D.'s NPI is 1174765192 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.